A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

PURPOSE: Although doxorubicin chemotherapy is commonly applied for treating different malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical use. The use of silymarin/silibinin may mitigate the doxorubicin-induced cardiac adverse effects. For this aim, the pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Mandeep, Kadhim, Mustafa M., Turki Jalil, Abduladheem, Oudah, Shamam Kareem, Aminov, Zafar, Alsaikhan, Fahad, Jawhar, Zanko Hassan, Ramírez-Coronel, Andrés Alexis, Farhood, Bagher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173635/
https://www.ncbi.nlm.nih.gov/pubmed/37165384
http://dx.doi.org/10.1186/s12935-023-02936-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173635/
https://www.ncbi.nlm.nih.gov/pubmed/37165384
http://dx.doi.org/10.1186/s12935-023-02936-4

Ejemplares similares